miR-425 Suppresses EMT and the Development of TNBC (Triple-Negative Breast Cancer) by Targeting the TGF-β 1/Smad 3 Signaling Pathway

RSC Advances - United Kingdom
doi 10.1039/c8ra08872a
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Royal Society of Chemistry (RSC)

Related search

G3BP1 Activates the TGF-β/Smad Signaling Pathway to Promote Gastric Cancer

OncoTargets and Therapy
OncologyPharmacology
2019English

SALL4 Activates TGF-β/SMAD Signaling Pathway to Induce EMT and Promote Gastric Cancer Metastasis

Cancer Management and Research
Oncology
2018English

TGF-? Induced TMEPAI/PMEPA1 Inhibits Canonical Smad Signaling Through R-Smad Sequestration and Promotes Non-Canonical PI3K/Akt Signaling by Reducing PTEN in Triple Negative Breast Cancer

Genes and Cancer
Cancer ResearchGenetics
2014English

Development of a Vaccine Targeting Triple-Negative Breast Cancer

2013English

Roles of TGF-β/Smad Signaling Pathway in Pathogenesis and Development of Gluteal Muscle Contracture

Connective Tissue Research
Sports MedicineCell BiologyMolecular BiologyBiochemistryRheumatologyOrthopedics
2014English

McT-1/miR-34a/Il-6/Il-6r Signaling Axis Promotes EMT Progression, Cancer Stemness and M2 Macrophage Polarization in Triple-Negative Breast Cancer

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2019English

AHNAK Suppresses Tumour Proliferation and Invasion by Targeting Multiple Pathways in Triple-Negative Breast Cancer

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2017English

MicroRNA‑124 Suppresses Cell Proliferation and Invasion of Triple Negative Breast Cancer Cells by Targeting STAT3

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2019English

Suppression of KIF3A Inhibits Triple Negative Breast Cancer Growth and Metastasis by Repressing Rb‐E2F Signaling and EMT

Cancer Science
Cancer ResearchMedicineOncology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy